4.8 Article

Development and Validation of a Combined Glycolysis and Immune Prognostic Model for Melanoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Immunometabolic Interplay in the Tumor Microenvironment

Irem Kaymak et al.

Summary: The study discusses the metabolic characteristics of immune cells in the tumor microenvironment and proposes future research directions.

CANCER CELL (2021)

Review Oncology

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma

Shaojie Wu et al.

Summary: Tumor cells rewire their metabolism to meet increased nutritional demands, interacting with the tumor microenvironment (TME) to maintain survival and expansion. Understanding the relationship between metabolic changes and the TME in multiple myeloma is crucial for cancer progression.

FRONTIERS IN ONCOLOGY (2021)

Article Multidisciplinary Sciences

Metabolic support of tumour-infiltrating regulatory T cells by lactic acid

McLane J. Watson et al.

Summary: T-reg cells exhibit broad heterogeneity in glucose metabolism within normal and transformed tissues, utilizing an alternative metabolic pathway to maintain their suppressive function and proliferation. Glucose uptake is correlated with poorer suppressive function and long-term instability, while high-glucose conditions impair T-reg cell function and stability. Additionally, T-reg cells upregulate pathways involved in the metabolism of lactic acid, with lactate uptake being dispensable for peripheral T-reg cells but required intratumorally for slowed tumor growth and increased response to immunotherapy.

NATURE (2021)

Review Oncology

Shifting the Gears of Metabolic Plasticity to Drive Cell State Transitions in Cancer

Zhengwei Wu et al.

Summary: Metabolic adaptation allows cancer cells to survive and thrive in diverse environments, maintain stemness, drive transition, and resist therapy. This plasticity in metabolism provides therapeutic opportunities for novel treatments.

CANCERS (2021)

Article Oncology

A Four-Gene-Based Prognostic Model Predicts Overall Survival in Patients With Cutaneous Melanoma

Xiaoxia Tong et al.

Summary: This study identified four novel prognostic genes for cutaneous melanoma (CM) and established an effective risk score model through gene expression analysis. The high-risk group predicted by the model showed a significantly shortened survival, indicating its potential for guiding therapeutic strategies for CM patients. Additional clinical trials are required to validate the findings.

FRONTIERS IN ONCOLOGY (2021)

Review Immunology

Lactate modulation of immune responses in inflammatory versus tumour microenvironments

Michelangelo Certo et al.

Summary: The microenvironments of cancerous tissues and tissues affected by chronic inflammatory diseases exhibit different immune states but similar metabolic states. Understanding the metabolic signature allows for therapeutic intervention to reset metabolite availability and correct dysregulated immune states.

NATURE REVIEWS IMMUNOLOGY (2021)

Article Biotechnology & Applied Microbiology

High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia

Yan Liu et al.

CANCER GENE THERAPY (2020)

Review Immunology

The IFITM protein family in adaptive immunity

Diana C. Yanez et al.

IMMUNOLOGY (2020)

Review Multidisciplinary Sciences

Metabolic reprogramming and cancer progression

Brandon Faubert et al.

SCIENCE (2020)

Article Biotechnology & Applied Microbiology

Identification and Validation of Prognostically Relevant Gene Signature in Melanoma

Yali Gao et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Article Oncology

A twelve-gene signature for survival prediction in malignant melanoma patients

Le-Bin Song et al.

ANNALS OF TRANSLATIONAL MEDICINE (2020)

Review Cell Biology

Mechanisms and Implications of Metabolic Heterogeneity in Cancer

Jiyeon Kim et al.

CELL METABOLISM (2019)

Review Medicine, General & Internal

Melanoma

Dirk Schadendorf et al.

LANCET (2018)

Review Oncology

Targeted agents and immunotherapies: optimizing outcomes in melanoma

Jason J. Luke et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Review Immunology

Metabolic Hallmarks of Tumor and immune Cells in the Tumor Microenvironment

Kathrin Renner et al.

FRONTIERS IN IMMUNOLOGY (2017)

Review Oncology

Tumour acidosis: from the passenger to the driver's seat

Cyril Corbet et al.

NATURE REVIEWS CANCER (2017)

Review Oncology

From melanocytes to melanomas

A. Hunter Shain et al.

NATURE REVIEWS CANCER (2016)

Article Biochemistry & Molecular Biology

G Protein-Coupled Receptor 87 (GPR87) Promotes Cell Proliferation in Human Bladder Cancer Cells

Xia Zhang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Gastroenterology & Hepatology

Semaphorin 4D and hypoxia-inducible factor-1α overexpression is related to prognosis in colorectal carcinoma

Jin-Shen Wang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Article Peripheral Vascular Disease

Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients

Huidong Liu et al.

MICROVASCULAR RESEARCH (2014)

Review Immunology

Integrating canonical and metabolic signalling programmes in the regulation of T cell responses

Kristen N. Pollizzi et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Article Oncology

Metabolic Reprogramming of the Immune Response in the Tumor Microenvironment

Susan A. McCarthy et al.

CANCER BIOLOGY & THERAPY (2013)

Article Dermatology

Update on the Current State of Melanoma Incidence

Emily G. Little et al.

DERMATOLOGIC CLINICS (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Multidisciplinary Sciences

Structural basis of semaphorin-plexin signalling

Bert J. C. Janssen et al.

NATURE (2010)

Article Biochemistry & Molecular Biology

IFITM1 plays an essential role in the antiproliferative action of interferon-γ

G. Yang et al.

ONCOGENE (2007)